首页> Journal of gastrointestinal oncology> Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial.

Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial.

导出 OA

翻译打印收藏纠错

第一作者： Sidra,Anwar

第一单位： 1 Department of Internal Medicine, State University of New York, Buffalo NY, USA ; 2 Department of Biostatistics, Roswell Park Cancer Institute, Buffalo NY, USA ; 3 Department of Biostatistics, State University of New York, Buffalo NY, USA ; 4 Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Centre, Houston TX, USA ; 5 Department of Medicine, Roswell Park Cancer Institute, Buffalo NY, USA.

作者： Sidra,Anwar ^[1] ; Wei,Tan ^[1] ; Jinhee,Yu ^[1] ; Alan,Hutson ^[1] ; Milind,Javle ^[1] ; Renuka,Iyer ^[1]

作者单位： 1 Department of Internal Medicine, State University of New York, Buffalo NY, USA ; 2 Department of Biostatistics, Roswell Park Cancer Institute, Buffalo NY, USA ; 3 Department of Biostatistics, State University of New York, Buffalo NY, USA ; 4 Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Centre, Houston TX, USA ; 5 Department of Medicine, Roswell Park Cancer Institute, Buffalo NY, USA. ^[1]

关键词 Quality of life (QoL)biomarkers neoplasm, European organization for research and treatment of cancer (EORTC)outcomes palliative care pancreas pancreatic cancer supportive oncology

DOI 10.3978/j.issn.2078-6891.2014.070

PMID 25436122

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交